Get notified when MD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPediatrix reaffirms 2026 guidance, reports stable Q2 payor mix amid sector headwinds
Filed July 15, 2026 · Period ending July 15, 2026 · ~1 min read
Key Changes
-
high
Reaffirms full-year 2026 Adjusted EBITDA guidance of $280-300M, signaling confidence that Q2 stability will continue through year-end despite broader healthcare sector pressures.
Exhibit 99.1 view on EDGAR → -
high
Q2 2026 payor mix remained stable and unchanged from recent trends, contrasting with unfavorable shifts (patients moving to lower-reimbursing plans) reported by other healthcare providers.
Exhibit 99.1 view on EDGAR → -
medium
No material changes in other net revenue trends during Q2 2026 compared to recent periods, indicating consistent performance across utilization, pricing, and collections.
Exhibit 99.1 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.
Partner
Trade MD commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 20, 2026 · How we verify